No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff. NEW YORK, March 31, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of ordinary shares of ICON plc (NASDAQ: ICLR) between July 27 ...

NEW YORK, March 31, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of ICON Public Limited Company (NASDAQ: ICLR). Shareholders who purchased shares of ICLR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/icon-public-limited-company-loss-submission-form/? id=139399&from=4 CLASS ...

Core Viewpoint - Rosen Law Firm is reminding investors who purchased ordinary shares of ICON plc between July 27, 2023, and October 23, 2024, about the April 11, 2025, deadline to become lead plaintiffs in a class action lawsuit [1]. Group 1: Class Action Details - Investors who bought ICON shares during the specified period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and interested parties must move the Court by April 11, 2025, to serve as lead plaintiff [2]. - The Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions [3]. Group 2: Allegations Against ICON - The lawsuit alleges that ICON made false and misleading statements regarding its business performance, including suffering a material loss of business due to customer cost reductions and funding limitations [4]. - It is claimed that ICON's service offerings were insufficient to mitigate the adverse effects of a significant market downturn, and that requests for proposals were primarily used for price discovery rather than indicating actual client demand [4]. - The lawsuit also states that ICON's two largest customers were diversifying their clinical research organization providers away from ICON, leading to a misrepresentation of client demand and a failure to meet revenue and earnings per share guidance [4].

Core Viewpoint - A class action securities lawsuit has been filed against ICON Public Limited Company, alleging securities fraud that negatively impacted investors between July 27, 2023, and October 23, 2024 [1][2]. Group 1: Allegations of Fraud - The lawsuit claims that ICON suffered a material loss of business due to customer cost reduction measures and funding limitations affecting its client base [2]. - It is alleged that ICON's service offerings were inadequate to protect the company from a significant market downturn [2]. - The requests for proposals from biotechnology customers were reportedly used as price discovery tools, not reflecting actual client demand [2]. - Customers of ICON are said to have canceled contracts, limited engagements, and delayed clinical trial work, failing to enter new contracts at historical rates [2]. - The two largest customers of ICON were diversifying their clinical research organization providers away from the company [2]. - As a result of these issues, ICON's reported business metrics misrepresented actual client demand for its services [2]. - The company was tracking significantly below its 2024 revenue and EPS guidance, which lacked a reasonable factual basis [2]. Group 2: Legal Process and Participation - Investors who suffered losses during the relevant time frame have until April 11, 2025, to request appointment as lead plaintiff [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees [3]. Group 3: Firm Background - Levi & Korsinsky has a history of securing hundreds of millions of dollars for shareholders and has extensive expertise in complex securities litigation [4]. - The firm has been recognized as one of the top securities litigation firms in the United States for seven consecutive years [4].

Core Viewpoint - The ICON PLC class action lawsuit alleges that the company and its executives made misleading statements regarding its business performance and failed to disclose significant operational challenges, leading to substantial financial losses for investors during the specified class period [1][2][3]. Group 1: Allegations Against ICON - The lawsuit claims that ICON suffered a material loss of business due to customer cost reduction measures and funding limitations impacting its client base [2]. - It is alleged that ICON's Functional Service Provision (FSP) and hybrid model offerings were inadequate to mitigate the effects of a market downturn [2]. - The requests for proposals from biotechnology customers were reportedly used as price discovery tools rather than indicative of actual client demand [2]. - Customers canceled contracts, limited engagements, and delayed clinical trial work, which negatively affected ICON's business [2]. - Two of ICON's largest customers were diversifying their CRO providers away from ICON, further impacting its business [2]. - As a result of these issues, ICON's reported net new business awards and book-to-bill metrics misrepresented actual client demand [2]. - Consequently, ICON was tracking significantly below its 2024 revenue and EPS guidance, which lacked a reasonable factual basis [2]. Group 2: Financial Performance - On October 23, 2024, ICON reported quarterly revenues of $2.03 billion, missing consensus estimates of $2.13 billion by over $100 million [3]. - The company's net new business wins declined sequentially to $2.3 billion from $2.6 billion in the prior quarter [3]. - ICON's book-to-bill ratio fell to 1.15 from 1.22 in the previous quarter, indicating a decline in business performance [3]. - Following the announcement of these results, ICON's share price dropped by more than 20% over two trading sessions [3]. Group 3: Legal Process and Representation - Investors who purchased ICON shares during the class period can seek appointment as lead plaintiff in the class action lawsuit [5]. - The lead plaintiff is typically the investor with the greatest financial interest in the case and acts on behalf of all class members [5]. - Robbins Geller Rudman & Dowd LLP, the law firm representing the plaintiffs, has a strong track record in prosecuting investor class actions and has recovered significant monetary relief for investors [6][7].

Core Viewpoint - A class action securities lawsuit has been filed against ICON Public Limited Company, alleging securities fraud that negatively impacted investors between July 27, 2023, and October 23, 2024 [1][2]. Group 1: Allegations of Fraud - The lawsuit claims that ICON suffered a significant loss of business due to customer cost reduction measures and funding limitations affecting its client base [2]. - It is alleged that ICON's service offerings were inadequate to protect the company from a major market downturn [2]. - The requests for proposals from biotechnology customers were reportedly used primarily for price discovery, not reflecting actual client demand [2]. - Customers of ICON are said to have canceled contracts, reduced engagements, and delayed clinical trial work, leading to a decline in new contracts at historical rates [2]. - The two largest customers of ICON were diversifying their clinical research organization providers away from the company [2]. - As a result of these issues, ICON's reported business metrics misrepresented actual client demand for its services [2]. - Consequently, ICON was tracking significantly below its 2024 revenue and EPS guidance, which lacked a reasonable factual basis [2]. Group 2: Legal Process and Participation - Investors who suffered losses during the specified period have until April 11, 2025, to request to be appointed as lead plaintiff [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees [3]. Group 3: Firm Background - Levi & Korsinsky has a history of securing substantial settlements for shareholders and has been recognized as a leading firm in securities litigation [4].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of ICON Public Limited Company regarding a class action lawsuit due to alleged misleading statements and failure to disclose material information during the class period from July 27, 2023, to October 23, 2024 [1]. Allegations Summary - ICON is accused of suffering a material loss of business due to customer cost reduction measures and funding limitations impacting its client base [1]. - The company's functional service provision and hybrid model offerings were deemed insufficient to protect against a significant market downturn [1]. - Requests for proposals from biotechnology customers were primarily used for price discovery, not indicative of actual client demand [1]. - Customers canceled contracts, limited engagements, delayed clinical trial work, and failed to enter new contracts at historical rates [1]. - ICON's two largest customers were diversifying their clinical research organization providers away from the company [1]. - As a result of the above issues, ICON's reported net new business awards and book-to-bill metrics misrepresented actual client demand [1]. - Consequently, ICON was tracking significantly below the 2024 revenue and EPS guidance issued during the class period, which lacked a reasonable factual basis [1]. Next Steps for Shareholders - Shareholders are encouraged to register for the class action by April 11, 2025, to participate in the case without any cost or obligation [2]. - Registered shareholders will be enrolled in a portfolio monitoring software for status updates throughout the case lifecycle [2]. Firm's Mission - The Gross Law Firm aims to protect the rights of investors affected by deceit, fraud, and illegal business practices, ensuring companies adhere to responsible business practices [3].

Core Viewpoint - A class action has been filed against ICON PLC, alleging that the company misled investors regarding its business performance and client demand during the specified period [1][2]. Allegations - ICON PLC experienced a material loss of business due to customer cost reduction measures and funding limitations affecting its client base [1]. - The company's FSP and hybrid model offerings were insufficient to mitigate the adverse effects of a significant market downturn [1]. - Requests for proposals (RFPs) from biotechnology customers were primarily used for price discovery and did not reflect actual client demand [1]. - Customers canceled contracts, reduced engagements, delayed clinical trial work, and failed to enter into new contracts at historical rates [1]. - ICON's two largest customers were diversifying their CRO providers away from the company [1]. - As a result of the above factors, ICON's reported net new business awards and book-to-bill metrics misrepresented actual client demand [1]. - Consequently, ICON was tracking significantly below its 2024 revenue and EPS guidance, which lacked a reasonable factual basis [1]. Impact on Stock Price - Following the revelation of these issues, ICON's stock price dropped significantly, resulting in harm to investors [2]. Class Action Participation - Shareholders may be eligible to participate in the class action against ICON PLC, with a deadline to file as lead plaintiff by April 11, 2025 [3].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased ordinary shares of ICON plc between July 27, 2023, and October 23, 2024, about the April 11, 2025, deadline to become a lead plaintiff in a class action lawsuit [1] Group 1: Class Action Details - Investors who bought ICON shares during the specified period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1] - A class action lawsuit has already been filed, and interested parties must move the Court by April 11, 2025, to serve as lead plaintiff [2] Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions, highlighting its own achievements in this area [3] - The firm has secured significant settlements for investors, including over $438 million in 2019, and has been ranked highly for its performance in securities class action settlements [3] Group 3: Allegations Against ICON - The lawsuit alleges that ICON made false and misleading statements regarding its business performance, including suffering from a material loss of business due to customer cost reductions and funding limitations [4] - It is claimed that ICON's service offerings were insufficient to mitigate the effects of a market downturn, and that client demand was misrepresented [4] - The lawsuit also states that ICON's largest customers were diversifying away from the company, leading to a significant discrepancy between reported business metrics and actual client demand [4]

Core Viewpoint - A securities class action lawsuit has been filed against ICON Public Limited Company for allegedly making materially false and misleading statements regarding its business operations and financial health during the Class Period from July 27, 2023, to October 23, 2024 [1]. Allegations of Misconduct - The lawsuit claims that ICON failed to disclose significant business losses due to customer cost reduction measures and funding limitations affecting its client base [2]. - It is alleged that ICON's hybrid model offerings were inadequate to protect the company from a market downturn [2]. - Requests for proposals from biotechnology customers were reportedly used as price discovery tools rather than reflecting actual client demand [2]. - Customers of ICON are said to have canceled contracts, reduced engagements, and delayed clinical trial work, impacting new contract opportunities [2]. - The two largest customers of ICON were diversifying their provider base away from the company [2]. - As a result of these issues, ICON's reported business metrics misrepresented actual client demand for its services [2]. - Positive statements made by ICON regarding its business prospects were claimed to be materially misleading [2]. Lead Plaintiff Process - Investors in ICON have until April 11, 2025, to seek appointment as a lead plaintiff representative in the class action [3]. - A lead plaintiff acts on behalf of all class members and selects counsel to represent the class [3]. - Participation as a lead plaintiff does not affect the ability to share in any recovery from the lawsuit [3].